{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T02:40:35Z","timestamp":1772332835083,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Otsuka Pharmaceutical Development & Commercialization Inc."},{"DOI":"10.13039\/501100018864","name":"Otsuka Canada Pharmaceutical Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018864","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021138","name":"Lundbeck Canada Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021138","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patient-reported outcomes can measure health aspects that are meaningful to patients, such as \u2018life engagement\u2019 in major depressive disorder (MDD). Expert psychiatrists recently identified ten items from the Inventory of Depressive Symptomatology Self-Report (IDS-SR) that can be used to measure patient life engagement. This study aimed to explore the concept of patient life engagement and provide support for the IDS-SR<jats:sub>10<\/jats:sub> Life Engagement subscale from the patient perspective.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Semi-structured video interviews were conducted with adults with MDD in the United States. Patients were asked if they ever felt engaged with life, and how this affected their feelings, activities, socializing, and thoughts. Then, patients discussed the ten expert-selected IDS-SR items, and rated the relevance of all 30 items to patient life engagement on a 4-point scale.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients (N\u2009=\u200920) understood the \u2018engaged with life\u2019 concept and could provide examples from their own lives, such as increased energy\/motivation (100%), being more social\/spending time with others (85%), being more communicative (80%), and having better mood (75%). Nineteen patients (95%) indicated that all ten IDS-SR<jats:sub>10<\/jats:sub> Life Engagement items were relevant to patient life engagement, and nine of the ten items had a mean score\u2009\u2265\u20093 (moderately relevant). Four additional items (all relating to mood) also scored\u2009\u2265\u20093.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Patients found the concept of life engagement to be important and relatable, and confirmed the IDS-SR<jats:sub>10<\/jats:sub> captures the defining non-mood-related aspects of patient life engagement. This research supports the relevance of patient life engagement as a potential clinical outcome beyond core mood symptoms, and the use of the IDS-SR<jats:sub>10<\/jats:sub> Life Engagement subscale in patient-oriented research.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41687-022-00517-z","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T21:03:02Z","timestamp":1665608582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Exploring life engagement from the perspective of patients with major depressive disorder: a study using patient interviews"],"prefix":"10.1186","volume":"6","author":[{"given":"Fran\u00e7ois","family":"Therrien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stine R.","family":"Meehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Dine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Michelle","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin M.","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"issue":"1","key":"517_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1176\/appi.ajp.163.1.148","volume":"163","author":"M Zimmerman","year":"2006","unstructured":"Zimmerman M, McGlinchey JB, Posternak MA, Friedman M, Attiullah N, Boerescu D (2006) How should remission from depression be defined? The depressed patient\u2019s perspective. Am J Psychiatry 163(1):148\u2013150","journal-title":"Am J Psychiatry"},{"key":"517_CR2","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jad.2014.12.004","volume":"174","author":"K Demyttenaere","year":"2015","unstructured":"Demyttenaere K, Donneau AF, Albert A, Ansseau M, Constant E, van Heeringen K (2015) What is important in being cured from depression? Discordance between physicians and patients (1). J Affect Disord 174:390\u2013396","journal-title":"J Affect Disord"},{"issue":"3","key":"517_CR3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s43441-019-00106-1","volume":"54","author":"CM Kieffer","year":"2020","unstructured":"Kieffer CM, Miller AR, Chacko B, Robertson AS (2020) FDA reported use of patient experience data in 2018 drug approvals. Ther Innov Regul Sci 54(3):709\u2013716","journal-title":"Ther Innov Regul Sci"},{"issue":"23","key":"517_CR4","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1001\/jama.2015.15818","volume":"314","author":"NL Hunter","year":"2015","unstructured":"Hunter NL, O\u2019Callaghan KM, Califf RM (2015) Engaging patients across the spectrum of medical product development: view from the US Food and Drug Administration. JAMA 314(23):2499\u20132500","journal-title":"JAMA"},{"key":"517_CR5","unstructured":"European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) (2020) ICH reflection paper on proposed ICH guideline work to advance patient focused drug development. European Medicines Agency, Amsterdam, The Netherlands. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-reflection-paper-proposed-ich-guideline-work-advance-patient-focused-drug-development_en.pdf. Accessed 31 Jan 2022"},{"key":"517_CR6","first-page":"61","volume":"6","author":"T Weldring","year":"2013","unstructured":"Weldring T, Smith SMS (2013) Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs). Health Serv Insights 6:61\u201368","journal-title":"Health Serv Insights"},{"key":"517_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2147\/PROM.S156279","volume":"9","author":"R Mercieca-Bebber","year":"2018","unstructured":"Mercieca-Bebber R, King MT, Calvert MJ, Stockler MR, Friedlander M (2018) The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient Relat Outcome Meas 9:353\u2013367","journal-title":"Patient Relat Outcome Meas"},{"key":"517_CR8","unstructured":"European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) (2016) Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man: the use of patient-reported outcome (PRO) measures in oncology studies. European Medicines Agency, London, United Kingdom. https:\/\/www.ema.europa.eu\/en\/documents\/other\/appendix-2-guideline-evaluation-anticancer-medicinal-products-man_en.pdf. Accessed 31 Jan 2022"},{"key":"517_CR9","unstructured":"US Food and Drug Administration (2009) Guidance for industry\u2014patient-reported outcome measures: use in medical product development to support labeling claims. Food and Drug Administration, Rockville, MD. https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm193282.pdf. Accessed 24 Apr 2022"},{"issue":"1","key":"517_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s41687-021-00380-4","volume":"5","author":"C Weiss","year":"2021","unstructured":"Weiss C, Meehan SR, Brown TM et al (2021) Effects of adjunctive brexpiprazole on calmness and life engagement in major depressive disorder: post hoc analysis of patient-reported outcomes from clinical trial exit interviews. J Patient Rep Outcomes 5(1):128","journal-title":"J Patient Rep Outcomes"},{"issue":"1","key":"517_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13195-018-0381-z","volume":"10","author":"D Bartr\u00e9s-Faz","year":"2018","unstructured":"Bartr\u00e9s-Faz D, Cattaneo G, Solana J, Tormos JM, Pascual-Leone A (2018) Meaning in life: resilience beyond reserve. Alzheimers Res Ther 10(1):47","journal-title":"Alzheimers Res Ther"},{"key":"517_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jad.2018.09.027","volume":"243","author":"JD Rosenblat","year":"2019","unstructured":"Rosenblat JD, Simon GE, Sachs GS et al (2019) Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression. J Affect Disord 243:116\u2013120","journal-title":"J Affect Disord"},{"issue":"6","key":"517_CR13","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1037\/0022-3514.57.6.1069","volume":"57","author":"CD Ryff","year":"1989","unstructured":"Ryff CD (1989) Happiness is everything, or is it? Explorations on the meaning of psychological well-being. J Pers Soc Psychol 57(6):1069\u20131081","journal-title":"J Pers Soc Psychol"},{"issue":"4","key":"517_CR14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1037\/0022-3514.69.4.719","volume":"69","author":"CD Ryff","year":"1995","unstructured":"Ryff CD, Keyes CLM (1995) The structure of psychological well-being revisited. J Pers Soc Psychol 69(4):719\u2013727","journal-title":"J Pers Soc Psychol"},{"issue":"2","key":"517_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2307\/2787065","volume":"61","author":"CLM Keyes","year":"1998","unstructured":"Keyes CLM (1998) Social well-being. Soc Psychol Q 61(2):121\u2013140","journal-title":"Soc Psychol Q"},{"issue":"6","key":"517_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1192\/bjp.bp.110.083733","volume":"199","author":"M Leamy","year":"2011","unstructured":"Leamy M, Bird V, Le Boutillier C, Williams J, Slade M (2011) Conceptual framework for personal recovery in mental health: systematic review and narrative synthesis. Br J Psychiatry 199(6):445\u2013452","journal-title":"Br J Psychiatry"},{"key":"517_CR17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jad.2021.12.032","volume":"299","author":"E Morton","year":"2022","unstructured":"Morton E, Foxworth P, Dardess P et al (2022) \u201cSupporting Wellness\u201d: a depression and bipolar support alliance mixed-methods investigation of lived experience perspectives and priorities for mood disorder treatment. J Affect Disord 299:575\u2013584","journal-title":"J Affect Disord"},{"issue":"1","key":"517_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1207\/s15327752jpa4901_13","volume":"49","author":"E Diener","year":"1985","unstructured":"Diener E, Emmons RA, Larsen RJ, Griffin S (1985) The satisfaction with life scale. J Pers Assess 49(1):71\u201375","journal-title":"J Pers Assess"},{"issue":"2","key":"517_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1037\/0033-2909.125.2.276","volume":"125","author":"E Diener","year":"1999","unstructured":"Diener E, Suh EM, Lucas RE, Smith HL (1999) Subjective well-being: three decades of progress. Psychol Bull 125(2):276\u2013302","journal-title":"Psychol Bull"},{"issue":"4","key":"517_CR20","doi-asserted-by":"publisher","first-page":"LU21112AH1","DOI":"10.4088\/JCP.LU21112AH1","volume":"83","author":"CU Correll","year":"2022","unstructured":"Correll CU, Ismail Z, McIntyre RS, Rafeyan R, Thase ME (2022) Patient functioning and life engagement: unmet needs in major depressive disorder and schizophrenia. J Clin Psychiatry 83(4):LU21112AH1","journal-title":"J Clin Psychiatry"},{"key":"517_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1477-7525-5-63","volume":"5","author":"R Tennant","year":"2007","unstructured":"Tennant R, Hiller L, Fishwick R et al (2007) The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes 5:63","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"517_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s41687-022-00468-5","volume":"6","author":"RS McIntyre","year":"2022","unstructured":"McIntyre RS, Ismail Z, Watling CP et al (2022) Patient-reported outcome measures for life engagement in mental health: a systematic review. J Patient Rep Outcomes 6(1):62","journal-title":"J Patient Rep Outcomes"},{"issue":"2","key":"517_CR23","first-page":"321","volume":"29","author":"J Endicott","year":"1993","unstructured":"Endicott J, Nee J, Harrison W, Blumenthal R (1993) Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 29(2):321\u2013326","journal-title":"Psychopharmacol Bull"},{"issue":"3","key":"517_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1017\/S0033291700035558","volume":"26","author":"AJ Rush","year":"1996","unstructured":"Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH (1996) The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 26(3):477\u2013486","journal-title":"Psychol Med"},{"key":"517_CR25","unstructured":"Thase ME, Pedersen AM, Ismail Z et al (2019) Efficacy of adjunctive brexpiprazole in adults with MDD: improvement of patient engagement based on selected items from the Inventory of Depressive Symptomatology Self-Report (IDS-SR) scale. Poster presented at the 32nd annual Psych Congress, San Diego, CA, 3\u20136 October 2019. https:\/\/www.hmpgloballearningnetwork.com\/site\/pcn\/posters\/efficacy-adjunctive-brexpiprazole-adults-mdd-improvement-patient-engagement-based-selected. Accessed 31 Jan 2022"},{"key":"517_CR26","doi-asserted-by":"publisher","DOI":"10.4135\/9781412983655","volume-title":"Cognitive interviewing: a tool for improving questionnaire design","author":"GB Willis","year":"2005","unstructured":"Willis GB (2005) Cognitive interviewing: a tool for improving questionnaire design. SAGE Publications, Inc., Thousand Oaks, CA"},{"issue":"2","key":"517_CR27","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1037\/1528-3542.3.2.194","volume":"3","author":"DR Carney","year":"2003","unstructured":"Carney DR, Harrigan JA (2003) It takes one to know one: interpersonal sensitivity is related to accurate assessments of others\u2019 interpersonal sensitivity. Emotion 3(2):194\u2013200","journal-title":"Emotion"},{"key":"517_CR28","unstructured":"Inventory of Depressive Symptomatology (Self-Report) (IDS-SR). https:\/\/ebbp.org\/resources\/IDS-SR%20English.pdf. Accessed 31 Jan 2022"},{"issue":"23","key":"517_CR29","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1111\/j.1365-2702.2009.02939.x","volume":"18","author":"K Bannigan","year":"2009","unstructured":"Bannigan K, Watson R (2009) Reliability and validity in a nutshell. J Clin Nurs 18(23):3237\u20133243","journal-title":"J Clin Nurs"},{"issue":"1","key":"517_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12874-019-0867-9","volume":"19","author":"M Krouwel","year":"2019","unstructured":"Krouwel M, Jolly K, Greenfield S (2019) Comparing Skype (video calling) and in-person qualitative interview modes in a study of people with irritable bowel syndrome\u2014an exploratory comparative analysis. BMC Med Res Methodol 19(1):219","journal-title":"BMC Med Res Methodol"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-022-00517-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-022-00517-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-022-00517-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T21:11:11Z","timestamp":1665609071000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-022-00517-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["517"],"URL":"https:\/\/doi.org\/10.1186\/s41687-022-00517-z","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,12]]},"assertion":[{"value":"4 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study materials were reviewed and approved by RTI International\u2019s institutional review board before any potential participants were informed or recruited for the study. Patients provided verbal informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"FT is a full-time employee of Otsuka Canada Pharmaceutical Inc. SRM is a full-time employee of H. Lundbeck A\/S. CW was a full-time employee of Otsuka Pharmaceutical Development & Commercialization Inc. at the time of this work. JD and TMB are full-time employees of RTI Health Solutions, contracted to conduct this research on behalf of the sponsor. EM is a full-time employee of Lundbeck Canada Inc.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}